Skip to main content

B12 derivatives as potential antivitamins

Image: National Institute of Standards and Technology, public domain, via Wikimedia Commons (licence). Cropped and resized. Image credits
  • Austrian Science Fund (FWF)
  • 1 May 2017 to 30 Apr 2021

Project page and source record Share by email Share on LinkedIn

Participants, websites and capabilities are shown to signed-in members.Sign in or request access

Project funded by Austrian Science Fund (FWF) (Lise Meitner), research institution: Universität Innsbruck. Approved FWF funding: EUR 161,220, as stated by the source. Runs 2017-05-01 to 2021-04-30 (status: ended). Keywords: B12 derivatives, Antimetabolites, Quantum Chemistry, Bioinorganic Complexes, QM/MM. Source: FWF Research Radar (FWF Open API) (national funding data, not CORDIS); selected because its keywords name quantum technology.

Original source.

Source: FWF Research Radar (FWF Open API), Austrian Science Fund (FWF). Retrieved 2026-10-28. Licence: CC0 1.0 (FWF Open API data). Selected metadata, adapted presentation; the publisher's record is authoritative. No endorsement by the source is implied. Licence: public domain dedication (CC0 1.0).

AI-assisted summary: The project "B12 derivatives as potential antivitamins" was funded by the Austrian Science Fund (FWF) with EUR 161,220 and ran from May 1, 2017, to April 30, 2021, at Universität Innsbruck. It focused on B12 derivatives and related fields, including quantum chemistry. Suggested technology pillar: simulation. Generated by AI from the public source text; it may contain errors and the original source is authoritative.

Source: fwf.ac.at · checked 28 Oct 2026 · AI-assisted summary